Phillip G. Febbo - Oct 2, 2023 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Oct 2, 2023
Transactions value $
$0
Form type
4
Date filed
10/4/2023, 04:35 PM
Previous filing
Mar 3, 2023
Next filing
Mar 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Award $0 +53.2K $0.00 53.2K Oct 2, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCYT Stock Option (right to buy) Award $0 +85.9K $0.00 85.9K Oct 2, 2023 Common Stock 85.9K $21.96 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units awarded on October 2, 2023 vest 25% on December 2, 2024 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
F2 The option becomes exercisable as to 25% of the shares on October 2, 2024, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.